Colgate-Palmolive (NYSE:CL) Price Target Cut to $77.00 by Analysts at Wells Fargo & Company

Colgate-Palmolive (NYSE:CL) had its target price trimmed by Wells Fargo & Company from $80.00 to $77.00 in a research report released on Monday morning,Benzinga reports. The firm currently has an underweight rating on the stock.

CL has been the subject of a number of other research reports. Raymond James Financial reduced their price objective on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research note on Monday, October 20th. UBS Group cut their price target on Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Barclays cut their price target on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, October 8th. Finally, Bank of America cut their price target on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Nine research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $90.00.

Colgate-Palmolive Stock Down 2.7%

Shares of NYSE:CL opened at $74.94 on Monday. The company has a market capitalization of $60.56 billion, a PE ratio of 21.05, a price-to-earnings-growth ratio of 4.44 and a beta of 0.34. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The business has a fifty day moving average price of $80.26 and a two-hundred day moving average price of $86.14. Colgate-Palmolive has a 1 year low of $74.54 and a 1 year high of $100.18.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business’s revenue for the quarter was up 1.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.91 EPS. Analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.8%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.26%.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in CL. Brighton Jones LLC boosted its stake in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares during the period. Wayfinding Financial LLC bought a new stake in shares of Colgate-Palmolive during the 1st quarter valued at about $69,000. World Investment Advisors boosted its position in shares of Colgate-Palmolive by 24.1% during the 1st quarter. World Investment Advisors now owns 11,769 shares of the company’s stock valued at $1,103,000 after acquiring an additional 2,282 shares during the last quarter. Concurrent Investment Advisors LLC boosted its position in shares of Colgate-Palmolive by 98.7% during the 1st quarter. Concurrent Investment Advisors LLC now owns 22,408 shares of the company’s stock valued at $2,100,000 after acquiring an additional 11,131 shares during the last quarter. Finally, Penserra Capital Management LLC boosted its position in shares of Colgate-Palmolive by 398.6% during the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company’s stock valued at $997,000 after acquiring an additional 8,515 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.